CAS: 1019158-02-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 2-(4-methoxyphenyl)-1-{[5-(2-nitrophenyl)furan-2-yl]methyl}pyrrolidine REF: IN-DA00ILCYCAS: 1019158-02-1 | 97% | To inquire | Mon 18 Nov 24 |
 | iST2-1 REF: 3D-UQB15802CAS: 1019158-02-1 | Min. 97 Area-% | 136.00 €~777.00 € | Wed 27 Nov 24 |
 | iST2-1 REF: TM-T72015CAS: 1019158-02-1 | - - - | 1,386.00 €~2,279.00 € | Tue 07 Jan 25 |
 | 2-(4-Methoxyphenyl)-1-{[5-(2-nitrophenyl)furan-2-yl]methyl}pyrrolidine REF: 10-F614198CAS: 1019158-02-1 | 97% | - - - | Discontinued product |
![2-(4-methoxyphenyl)-1-{[5-(2-nitrophenyl)furan-2-yl]methyl}pyrrolidine](https://static.cymitquimica.com/products/IN/thumb/DA00ILCY.jpg)
2-(4-methoxyphenyl)-1-{[5-(2-nitrophenyl)furan-2-yl]methyl}pyrrolidine
CAS:1019158-02-1
Formula:
C22H22N2O4
Purity:
97%
Molecular weight:
378.4211
Ref: IN-DA00ILCY
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 18 Nov 2024
iST2-1
CAS:1019158-02-1
iST2-1 is a regulatory protein that may play an important role in the pathogenesis of …
Formula:
C22H22N2O4
Purity:
Min. 97 Area-%
Color and Shape:
Clear Viscous Liquid
Molecular weight:
378.43 g/mol
Ref: 3D-UQB15802
| 5mg | 136.00 € | ||
| 10mg | 192.00 € | ||
| 25mg | 324.00 € | ||
| 50mg | 453.00 € | ||
| 100mg | 777.00 € |
Estimated delivery in United States, on Wednesday 27 Nov 2024
iST2-1
CAS:1019158-02-1
iST2-1 is a first-in-class ST2 inhibitor active in vivo.
Formula:
C22H22N2O4
Color and Shape:
Solid
Molecular weight:
378.42
Ref: TM-T72015
| 25mg | 1,386.00 € | ||
| 50mg | 1,805.00 € | ||
| 100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
![2-(4-Methoxyphenyl)-1-{[5-(2-nitrophenyl)furan-2-yl]methyl}pyrrolidine](https://static.cymitquimica.com/products/10/thumb/F614198.jpg)
2-(4-Methoxyphenyl)-1-{[5-(2-nitrophenyl)furan-2-yl]methyl}pyrrolidine
CAS:1019158-02-1
Purity:
97%
Molecular weight:
378.4280090332031
Ref: 10-F614198
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
